Inhibition of IRE1α-driven pro-survival pathways is a promising therapeutic application in acute myeloid leukemia
Oncotarget (2016) - Comments
pubmed: 26934650  doi: 10.18632/oncotarget.7702  issn: 1949-2553 

Haibo Sun, De-Chen Lin, Xiao Guo, Behzad Kharabi Masouleh, Sigal Gery, Qi Cao, Serhan Alkan, Takayuki Ikezoe, Chie Akiba, Ronald Paquette, Wenwen Chien, Carsten Müller-Tidow, Yang Jing, Konstantin Agelopoulos, Markus Müschen, Phillip H. Koeffler